Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.



October 20, 2016

NEW YORK/GENEVA, OCTOBER 20, 2016—A new cholera control strategy using a single-dose oral vaccine instead of two doses could be sufficient in protecting against the deadly disease during an outbreak, according to a study published by international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontiéres (MSF) in the Lancet Global Health this week.

October 13, 2016

As Kenya’s government-mandated closure of the Dadaab refugee camp draws nearer, MSF is urging the government of Kenya, the United Nations High Commission on Refugees (UNHCR) and donor countries to find an alternative to a policy that will send thousands of refugees back to war-ravaged Somalia.

October 12, 2016

“The World Health Organization’s annual look at the global state of tuberculosis this year makes for a shockingly bad report card: countries are failing to diagnose and treat millions of people with TB, which caused 1.8 million deaths last year. Governments need to get their heads out of the sand and realize that TB is not a disease consigned to the 1800s; we see and treat TB in our clinics every day, and it’s a deadly threat to all of us.

September 21, 2016

"Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the United Nations’s (UN) Political Declaration Antimicrobial Resistance, which recognizes the need to address – at the highest political levels – the complex issue of drug-resistant infections, which affect people in every part of the world. Now, governments have the responsibility to turn these words into action and fully implement nationally-tailored plans and global commitments to combat antimicrobial resistance (AMR).

September 20, 2016

MSF calls on Pfizer to match GSK’s move and offer the humanitarian community the lowest global price for this lifesaving vaccine

September 19, 2016

“After years of fighting for children caught in crises and desperately in need of the pneumonia vaccine, Doctors Without Borders/Médecins Sans Frontières is relieved to see that GlaxoSmithKline (GSK) finally plans to reduce its vaccine price for humanitarian organizations. GSK is leading the way in this commitment to children who are experiencing the most horrific of circumstances, while Pfizer continues to hide behind excuses and offer only piecemeal approaches to the humanitarian community.

September 16, 2016

"The sustainable development goals (SDGs) adopted with much fanfare just a year ago seek to end HIV, tuberculosis, and malaria by 2030. The replenishment of the Global Fund is the first concrete action taken by the international community since the adoption of these goals, and therefore a first test of the world leaders' will to make them a reality. Failure to reach the relatively modest Global Fund's replenishment target would be a clear message that the SDGs were but empty promises to the millions who, every year, continue to suffer and die from HIV, tuberculosis, and malaria."

September 14, 2016

New report exposes pharmaceutical industry failings and highlights new ways of researching and developing medicines that address public health needs.

August 25, 2016

Dr. Erlend Grønningen from Trondheim, Norway is a Doctors Without Borders/Médecins Sans Frontières (MSF) supervising medical doctor at Boost Hospital in Lashkar Gah, capital of Afghanistan’s Helmand province. Dr Gronningen arrived in Afghanistan in April, 2016, and primarily focuses on internal medicine, as well as the diagnosis and treatment of tuberculosis (TB). This is his second assignment with MSF, having worked in South Sudan in 2014.

July 21, 2016

Trade agreements and pressure on India’s ‘pharmacy of the developing world’ pose major threats to access